Vivani Medical, Inc.
Vivani Medical, Inc. (VANI) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Vivani Medical, Inc. (VANI), featuring income statements, balance sheets, and cash flow data.
Vivani Medical, Inc. (VANI) Income Statement & Financial Overview
View the income breakdown for Vivani Medical, Inc. VANI across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $199000.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $100000.00 | $99000.00 |
| Gross Profit | $199000.00 | $0.00 | -$100000.00 | -$99000.00 |
| Gross Profit Ratio | $1.00 | $0.00 | ||
| R&D Expenses | $4.30M | $4.20M | $3.51M | $3.73M |
| SG&A Expenses | $2.26M | $2.11M | $2.17M | $2.40M |
| Operating Expenses | $6.46M | $6.31M | $5.68M | $6.13M |
| Total Costs & Expenses | $6.76M | $6.31M | $5.68M | $6.23M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $89000.00 | $112000.00 | $100000.00 | $99000.00 |
| EBITDA | -$6.37M | -$6.20M | -$5.58M | -$6.13M |
| EBITDA Ratio | -$32.02 | |||
| Operating Income | -$6.46M | -$6.31M | -$5.68M | -$6.23M |
| Operating Income Ratio | -$32.46 | |||
| Other Income/Expenses (Net) | $410000.00 | $268000.00 | $325000.00 | $188000.00 |
| Income Before Tax | -$6.05M | -$6.04M | -$5.36M | -$6.04M |
| Income Before Tax Ratio | -$30.40 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $55724.00 |
| Net Income | -$6.05M | -$6.04M | -$5.36M | -$6.04M |
| Net Income Ratio | -$30.40 | |||
| EPS | -$0.11 | -$0.11 | -$0.10 | -$0.12 |
| Diluted EPS | -$0.11 | -$0.11 | -$0.10 | -$0.12 |
| Weighted Avg Shares Outstanding | $57.42M | $55.25M | $55.02M | $52.20M |
| Weighted Avg Shares Outstanding (Diluted) | $57.42M | $55.25M | $55.02M | $52.20M |
Over the last four quarters, Vivani Medical, Inc.'s revenue moved from $0.00 in Q1 2024 to $199000.00 in Q4 2024. Operating income in Q4 2024 was -$6.46M, with a strong operating margin of -3246%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Vivani Medical, Inc. remained robust at -$6.37M, reflecting operational efficiency. Net income dropped to -$6.05M, with an EPS of -$0.11. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan